Literature DB >> 8066221

The choice of the most appropriate microfertilization technique for human male factor infertility.

A O Trounson1.   

Abstract

Comparisons were made among techniques used to treat male factor infertility. Patients with semen quality below that recognized by World Health Organization criteria as normal had a better success rate when treated by gamete intrafallopian transfer than by in vitro fertilization (25% v. 7% pregnancy rate per patient). When < 2 x 10(6) motile sperm were recovered, the fertilization rate and embryo cleavage rate were higher for microdrop insemination than for conventional insemination. When 7000-370,000 motile sperm were recovered, microdrop insemination resulted in a higher fertilization rate (46%) and a higher incidence of pregnancies (23% of patients treated) than subzonal sperm microinjection (SUSM). However, for patients with 5000-50,000 motile sperm, the immediate transfer of SUSM oocytes to the Fallopian tube increased pregnancy rates for this technique to 24% of patients treated. Direct microinjection of epididymal sperm from azoospermic men into the cytoplasm of oocytes resulted in pronuclear formation in 27% of oocytes; in comparison, pronuclear formation occurred in 5% of SUSM oocytes. These data led to formulation of a logical treatment programme for male factor infertility.

Entities:  

Mesh:

Year:  1994        PMID: 8066221     DOI: 10.1071/rd9940037

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  2 in total

1.  Sperm:oocyte ratios in an in vitro fertilization (IVF) program.

Authors:  A Fiorentino; M C Magli; D Fortini; E Feliciani; A P Ferraretti; B Dale; L Gianaroli
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

Review 2.  Understanding fertilization through intracytoplasmic sperm injection (ICSI).

Authors:  Queenie V Neri; Bora Lee; Zev Rosenwaks; Khaled Machaca; Gianpiero D Palermo
Journal:  Cell Calcium       Date:  2013-11-15       Impact factor: 6.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.